1. Home
  2. DFH vs ENOV Comparison

DFH vs ENOV Comparison

Compare DFH & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dream Finders Homes Inc.

DFH

Dream Finders Homes Inc.

HOLD

Current Price

$18.47

Market Cap

1.7B

ML Signal

HOLD

Logo Enovis Corporation

ENOV

Enovis Corporation

HOLD

Current Price

$21.50

Market Cap

1.6B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
DFH
ENOV
Founded
2008
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Fluid Controls
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.6B
IPO Year
2021
2008

Fundamental Metrics

Financial Performance
Metric
DFH
ENOV
Price
$18.47
$21.50
Analyst Decision
Hold
Strong Buy
Analyst Count
2
8
Target Price
$26.00
$48.13
AVG Volume (30 Days)
425.9K
1.0M
Earning Date
02-24-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.84
N/A
Revenue
$4,671,814,000.00
$2,233,266,000.00
Revenue This Year
N/A
$9.22
Revenue Next Year
$4.14
$4.60
P/E Ratio
$6.47
N/A
Revenue Growth
15.98
11.57
52 Week Low
$16.59
$21.90
52 Week High
$31.50
$49.38

Technical Indicators

Market Signals
Indicator
DFH
ENOV
Relative Strength Index (RSI) 47.54 28.45
Support Level $18.06 $22.50
Resistance Level $20.26 $24.46
Average True Range (ATR) 0.90 1.26
MACD -0.03 -0.35
Stochastic Oscillator 50.82 0.59

Price Performance

Historical Comparison
DFH
ENOV

About DFH Dream Finders Homes Inc.

Dream Finders Homes Inc is engaged in the home building business. The company's primary focus is on constructing and selling single-family homes across entry-level, first-time move-up, second-time move-up, and active adult markets. Its homebuilding operations are organized into four reportable segments: Southeast, Mid-Atlantic, Midwest, and Financial Services. It generates the majority of its revenue from the Midwest segment.

About ENOV Enovis Corporation

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

Share on Social Networks: